Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 2 (2005), Issue 8 (August)

1. Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
   Clin Cancer Res, 11(15): 5631-8. [Abstract] [Full-text]
2. A bifunctional targeted peptide that blocks HER-2 tyrosine kinase and disables mitochondrial function in HER-2-positive carcinoma cells.
   Cancer Res, 65(15): 6891-900. [Abstract] [Full-text]
3. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
   Cancer Res, 65(15): 6801-10. [Abstract] [Full-text]
4. Docetaxel/trastuzumab combination therapy for the treatment of breast cancer.
   Expert Opin Pharmacother, 6(9): 1555-64. [Abstract] [Full-text]
5. Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
   Expert Opin Pharmacother, 6(9): 1477-91. [Abstract] [Full-text]
6. Overview of the impact of conventional systemic therapies on breast cancer.
   Endocr Relat Cancer, 12: S9-S16. [Abstract] [Full-text]
7. Inhibitors of growth factor signalling.
   Endocr Relat Cancer, 12: S183-7. [Abstract] [Full-text]
8. Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines.
   Cancer Lett, 227(2): 201-12. [Abstract] [Full-text]
9. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
   Eur Urol, 48(3): 400-7. [Abstract] [Full-text]
10. Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer.
    Invest New Drugs, 23(5): 391-409. [Abstract] [Full-text]
11. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals.
    J Am Chem Soc, 127(35): 12387-91. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.